| Peer-Reviewed

Radiological Profile of Patients with COVID-19 at the LOMO Medical Center

Received: 31 May 2021    Accepted: 15 June 2021    Published: 22 June 2021
Views:       Downloads:
Abstract

Background and aim: COVID-19 is a public health problem but radiological data are still absent in developing countries. The aim of the study was to determine preliminary data from patients hospitalized for COVID-19 at the LOMO Medical Center during the first and second waves. Methods: Cross-sectional and descriptive study carried out in 83 patients with COVID-19 at the Lomo Medical Center in Limete during the period from March 19, 2020 to January 24, 2021. The clinical and radiological characteristics were studied. Results: The sample of our study is predominantly male (55%) over women (45%), resulting in a sex ratio of 1.2 (M/F). The results obtained from VS and D-dimer show high mean values in patients whose COVID-19 is confirmed positive but low in those from whom it is suspected/absent. The difference in means is statistically significant (p<0.05), the COVID-19 status was confirmed in 21.5% of cases in men against 17.1% of cases in women; the difference was not statistically significant (p=0.159). He noted that interstitial lung disease and cardiomegaly were correlated with COVID 19 status (p<0.05). Conclusion: The main target of the SARS-CoV-2 virus is the lung, but multisystem involvement is possible.

Published in Central African Journal of Public Health (Volume 7, Issue 4)
DOI 10.11648/j.cajph.20210704.13
Page(s) 164-169
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

CODIV-19, Radiological Profile, Lomo, DRC

References
[1] National health commission of the people’s Republic of China. The latest situation of new coronavirus pneumonia. 2020.
[2] Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020 Jun; 55 (6): 105948.
[3] World Health Organization. Novel Coronavirus (2019-nCoV) situation reports. Cité le 28 mai 2020.
[4] Worldometer COVID-19 coronavirus pandemic. Last updated: June 14, 2020. Cité le 28 mai 2020).
[5] Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020; 323 (13): 1239-42.
[6] Placais L, Richier Q. COVID-19: clinical, biological and radiological characteristics in adults, infants and pregnant women. An upto-date review at the heart of the pandemic. Rev Med Interne. 2020; 41 (5): 308-18.
[7] Pan Y, Li X, Yang G, Fan J, Tang Y, Zhao J et al. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. J Infect. 2020 Apr 10; 81 (1): e28-e32.
[8] Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020 May 6. Epub 2020/05/07.
[9] Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20 (4): 425-34.
[10] Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020 Mar 16; ciaa 270. Epub 2020/03/17.
[11] Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARSCoV-2 infection diagnosis. J Med Virol. 2020 Feb 27; 10.1002/jmv.25727. Epub 2020/02/28.
[12] Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I et al. Novel Coronavirus infection (COVID-19) in humans: A scoping review and meta-analysis. J Clin Med. 2020 Mar 30; 9 (4): 941. Epub 2020/04/03.
[13] Louhaichi S, Allouche A, Baili H, Jrad S, Radhouani A, Greb D et al. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian caseseries. Tunis Med. 2020; 98 (4): 261-5.
[14] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708-20.
[15] Li K, Wu J, Wu F, Guo D, Chen L, Fang Z et al. The Clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020; 55 (6): 327-31.
[16] Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13; e200994. Epub 2020/03/14.
[17] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10229): 1054-62.
[18] Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395 (10223): 514-23.
[19] Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan. 2006; 15 (1): 26-8.
[20] Kanne JP. Chest CT findings in 2019 Nnovel Coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. 2020; 295 (1): 16-7.
[21] Fatima S, Ratnani I, Husain M, Surani S. Radiological findings in patients with COVID-19. Cureus. 2020; 12 (4): e7651.
[22] World Health organization. Coronavirus disease (COVID-19) pandemic. Cité le 28 mai 2020.
[23] Worldometer. COVID-19 coronavirus pandemic. Algérie. Cité le 28 mai 2020.
[24] Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020 Jun; 95 (6): 1138-1147. Epub 2020/05/08.
[25] Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ et al. Clinical characteristics of 140 patients infected with SARS-CoV2 in Wuhan, China. Allergy. 2020 Feb 19. Epub 2020/02/23.
[26] Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L et al. Chest CT findings in patients with Coronavirus disease 2019 and its relationship with clinical features. Invest Radiol. 2020; 55 (5): 257-61.
[27] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061-9.
[28] Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 Jun; 46 (6): 1099-1102.
[29] Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. COVID-19: pathogenesis of a multi-faceted disease. Rev Med Interne. 2020 May 27; 41 (6): 375-389.
[30] Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al. Baseline characteristics and outcomes of 1591 patients infectedwith SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020; 323 (16): 1574-81.
[31] Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18 (5): 1094-9.
Cite This Article
  • APA Style

    Benjamin Longo Mbenza, Aliocha Natuhoyila Nkodila, Evelyne Lukoki Luila, Christophe Mambueni Thamba, Gedeon Longo Longo, et al. (2021). Radiological Profile of Patients with COVID-19 at the LOMO Medical Center. Central African Journal of Public Health, 7(4), 164-169. https://doi.org/10.11648/j.cajph.20210704.13

    Copy | Download

    ACS Style

    Benjamin Longo Mbenza; Aliocha Natuhoyila Nkodila; Evelyne Lukoki Luila; Christophe Mambueni Thamba; Gedeon Longo Longo, et al. Radiological Profile of Patients with COVID-19 at the LOMO Medical Center. Cent. Afr. J. Public Health 2021, 7(4), 164-169. doi: 10.11648/j.cajph.20210704.13

    Copy | Download

    AMA Style

    Benjamin Longo Mbenza, Aliocha Natuhoyila Nkodila, Evelyne Lukoki Luila, Christophe Mambueni Thamba, Gedeon Longo Longo, et al. Radiological Profile of Patients with COVID-19 at the LOMO Medical Center. Cent Afr J Public Health. 2021;7(4):164-169. doi: 10.11648/j.cajph.20210704.13

    Copy | Download

  • @article{10.11648/j.cajph.20210704.13,
      author = {Benjamin Longo Mbenza and Aliocha Natuhoyila Nkodila and Evelyne Lukoki Luila and Christophe Mambueni Thamba and Gedeon Longo Longo and Herve-Alex Tukadila Kabangi and Serge Malenga and Ingrid Cecile Djuikoue and Etienne Mokondjimabe},
      title = {Radiological Profile of Patients with COVID-19 at the LOMO Medical Center},
      journal = {Central African Journal of Public Health},
      volume = {7},
      number = {4},
      pages = {164-169},
      doi = {10.11648/j.cajph.20210704.13},
      url = {https://doi.org/10.11648/j.cajph.20210704.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20210704.13},
      abstract = {Background and aim: COVID-19 is a public health problem but radiological data are still absent in developing countries. The aim of the study was to determine preliminary data from patients hospitalized for COVID-19 at the LOMO Medical Center during the first and second waves. Methods: Cross-sectional and descriptive study carried out in 83 patients with COVID-19 at the Lomo Medical Center in Limete during the period from March 19, 2020 to January 24, 2021. The clinical and radiological characteristics were studied. Results: The sample of our study is predominantly male (55%) over women (45%), resulting in a sex ratio of 1.2 (M/F). The results obtained from VS and D-dimer show high mean values in patients whose COVID-19 is confirmed positive but low in those from whom it is suspected/absent. The difference in means is statistically significant (pConclusion: The main target of the SARS-CoV-2 virus is the lung, but multisystem involvement is possible.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Radiological Profile of Patients with COVID-19 at the LOMO Medical Center
    AU  - Benjamin Longo Mbenza
    AU  - Aliocha Natuhoyila Nkodila
    AU  - Evelyne Lukoki Luila
    AU  - Christophe Mambueni Thamba
    AU  - Gedeon Longo Longo
    AU  - Herve-Alex Tukadila Kabangi
    AU  - Serge Malenga
    AU  - Ingrid Cecile Djuikoue
    AU  - Etienne Mokondjimabe
    Y1  - 2021/06/22
    PY  - 2021
    N1  - https://doi.org/10.11648/j.cajph.20210704.13
    DO  - 10.11648/j.cajph.20210704.13
    T2  - Central African Journal of Public Health
    JF  - Central African Journal of Public Health
    JO  - Central African Journal of Public Health
    SP  - 164
    EP  - 169
    PB  - Science Publishing Group
    SN  - 2575-5781
    UR  - https://doi.org/10.11648/j.cajph.20210704.13
    AB  - Background and aim: COVID-19 is a public health problem but radiological data are still absent in developing countries. The aim of the study was to determine preliminary data from patients hospitalized for COVID-19 at the LOMO Medical Center during the first and second waves. Methods: Cross-sectional and descriptive study carried out in 83 patients with COVID-19 at the Lomo Medical Center in Limete during the period from March 19, 2020 to January 24, 2021. The clinical and radiological characteristics were studied. Results: The sample of our study is predominantly male (55%) over women (45%), resulting in a sex ratio of 1.2 (M/F). The results obtained from VS and D-dimer show high mean values in patients whose COVID-19 is confirmed positive but low in those from whom it is suspected/absent. The difference in means is statistically significant (pConclusion: The main target of the SARS-CoV-2 virus is the lung, but multisystem involvement is possible.
    VL  - 7
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Faculty of Public Health, LOMO University Research, Kinshasa, Democratic Republic of the Congo